Company Profiles

driven by the PitchBook Platform

AiCuris

Description

Developer of antibacterial agents. The company engages in discovery, research and development of antiviral and antibacterial agents to treat infectious diseases.

2006

Founded

PRIVATE

Status

51-200

Employees

Grant

Latest Deal Type

$646M

Total Amount Raised

3

Investors

Description

Developer of antibacterial agents. The company engages in discovery, research and development of antiviral and antibacterial agents to treat infectious diseases.

Website:

www.aicuris.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

Friedrich-Ebert-Street 475 Building 302 D-42117 WuppertalGermany +49 (0)20 2317 63
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AiCuris's full profile, request a free trial.

AiCuris Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AiCuris Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Bayer PharmaCorporationMinority000 0000000 0000
Merck Capital VenturesCorporate Venture CapitalMinority000 0000000 0000
Thomas StrungmannAngel (individual)Minority000 0000000 0000
Bayer Pharma Corporation
Merck Capital Ventures Corporate Venture Capital
Thomas Strungmann Angel (individual)

AiCuris Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Holger ZimmermannChief Executive Officer
Holger SchmollChief Financial Officer
Holger Zimmermann Chief Executive Officer
Holger Schmoll Chief Financial Officer
Request full access to PitchBook